Top 20 Biopharma M&A of 2024 by Total Deal Value

By Ani Harutyunyan

Feb 6, 2025

Media Coverage

Using DealForma insights, PharmaShots highlights the Top 20 Biopharma M&A deals of 2024, led by Vertex’s $4.9B acquisition of Alpine. Read it here

DealForma Research

Biopharma Therapeutics and Platforms M&A – 2025 Review

March 9, 2026

Biopharma Therapeutics and Platforms R&D Partnerships – 2025 Review

February 26, 2026

Dermatology M&A – 2024-2025 Review

February 23, 2026

All of this by stage, disease indication, modality, target…

+ 0 k

Licensing Deals

+ 0 k

M&A

+ 0 k

Other Deals

+ 0 k

Funding Rounds

+ 0 k

Company Profiles

+ 0 k

Drug Sales Figures